Progentec is engaged in state of the art diagnostic interventions in therapeutic areas with a high level of unmet need.
Progentec Diagnostics's investors include OCA Ventures, Stanford University, Mayo Clinic Ventures, i2E, NMC Health.
Progentec Diagnostics is headquartered in Oklahoma City, United States.
Progentec is engaged in state of the art diagnostic interventions in therapeutic areas with a high level of unmet need.
Progentec Diagnostics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Progentec Diagnostics — Funding & Investors." VCBacked, April 9, 2026, https://www.vcbacked.co/company/progentec-diagnostics. Accessed October 31, 2026.
VCBacked. (2026). Progentec Diagnostics — Funding & Investors. Retrieved October 31, 2026, from https://www.vcbacked.co/company/progentec-diagnostics
{{cite web |title=Progentec Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/progentec-diagnostics |website=VCBacked |access-date=October 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated